Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)

Hafiz Talha Javed; Muhammad Hassan Akhtar; Sama Almasri; Ali Hamdan; Esha Tanveer; Abeeha Kaleem; Nabiha Kashif; Fatima Hamid; Muhammad Abdullah Yasin; Muhammad Qasim Qureshi; Huda Afzal; Divya Nayar; Saba Sattar

doi:10.1212/wnl.0000000000215772

June 9, 2026Neurology

Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)

View Full Paper

Ask AI

Bookmark

Share

Key Points

The central aim is to assess the effectiveness and safety of neuroprotective agents in Acute Ischemic Stroke patients undergoing endovascular treatment.
Systematic review and meta-analysis of neuroprotective agents like Edaravone-Dexborneol, uric acid, and NXY-059.
Comparison of treatment outcomes with standard care in AIS patients.
Evaluation of functional and cognitive outcomes from included studies.
Neuroprotective agents showed improved functional outcomes in patients undergoing endovascular treatment.
Cognitive profiles were positively impacted by certain neuroprotective agents compared to standard treatment.
Safety profiles of neuroprotective agents indicated no significant adverse effects in AIS patients.

Implication

Systematic review evaluates neuroprotective agents compared to standard care, emphasizing safety and function in AIS patients.

Abstract

We evaluated the functional, cognitive, and safety profiles of neuroprotective agents such as Edaravone-Dexborneol, uric acid, and NXY-059 compared to standard treatment in Acute Ischemic Stroke(AIS) patients undergoing endovascular treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Javed et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf393faef96ed7f055fc0 https://doi.org/10.1212/wnl.0000000000215772

View Full Paper

Ask AI

Bookmark

Share

Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)

Key Points

Implication

Abstract

Discussion

Cite This Study

Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading